The Validation of Multifactor Model of Plasma Aβ42 and Total-Tau in Combination With MoCA for Diagnosing Probable Alzheimer Disease

The Validation of Multifactor Model of Plasma Aβ42 and Total-Tau in Combination With MoCA for Diagnosing Probable Alzheimer Disease

Alzheimer disease (AD) has an insidious onset and heterogeneous clinical symptoms. The well-accepted biomarkers for clinical diagnosis of AD include β-amyloid (Aβ) deposition and pathologic tau level within cerebral spinal fluid (CSF) and imaging AD pathology such as positive emission tomography (PE...

Full description

Bibliographic Details
Main Authors: Fubin Jiao, Fang Yi, Yuanyuan Wang, Shouzi Zhang, Yanjun Guo, Wenjin Du, Ya Gao, Jingjing Ren, Haifeng Zhang, Lixin Liu, Haifeng Song, Luning Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Aging Neuroscience
Subjects:
Alzheimer disease
β-amyloid
tau
Montreal Cognitive Assessment
ultrasensitive immunomagnetic reduction
Online Access:https://www.frontiersin.org/article/10.3389/fnagi.2020.00212/full

Internet

https://www.frontiersin.org/article/10.3389/fnagi.2020.00212/full

Similar Items